Medications & Supplements/Prescription Drugs

Preferred Pharmaceuticals, Inc.: Cephalexin for Oral Suspension Recalled for Unidentified Impurity

Agency Publication Date: April 26, 2021

Summary

Preferred Pharmaceuticals, Inc. is recalling six bottles of Cephalexin for Oral Suspension, a generic version of Keflex (250 mg/5mL), due to the presence of an unidentified impurity. This impurity was detected during testing and indicates that the medication has failed quality and degradation standards. This specific recall affects product repackaged by Preferred Pharmaceuticals and manufactured by Ascend Laboratories, which was distributed to physicians in California.

Risk

The presence of unidentified impurities or degradation products means the medication does not meet safety and purity specifications, which could potentially impact the drug's effectiveness or cause unexpected side effects.

What You Should Do

Check your prescription bottle for Cephalexin for Oral Suspension (250 mg/5mL) with NDC number 68788-7529-1.
Verify if your bottle belongs to Lot B1121W with an expiration date of 04/2022.
Contact your healthcare provider or pharmacist immediately to discuss your treatment and determine if a replacement medication is necessary.
Return any unused portion of the recalled medication to the physician's office or pharmacy where you received it for a refund.
Contact Preferred Pharmaceuticals, Inc. at their Anaheim, CA facility for further instructions regarding this recall.
For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Healthcare provider consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL (100 mL)

Model:

NDC 68788-7529-1

Recall #: D-0342-2021

Lot Numbers:

B1121W (Exp.Date: 04/2022)

Date Ranges: Expiration Date: 04/2022

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 87719

Status: Active

Manufacturer: Preferred Pharmaceuticals, Inc.

Sold By: physicians located in CA

Manufactured In: United States

Units Affected: Six bottles

Distributed To: California

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your prescription bottle for Cephalexin for Oral Suspension (250 mg/5mL) with NDC number 68788-7529-1.

Verify if your bottle belongs to Lot B1121W with an expiration date of 04/2022.

Contact your healthcare provider or pharmacist immediately to discuss your treatment and determine if a replacement medication is necessary.

Return any unused portion of the recalled medication to the physician's office or pharmacy where you received it for a refund.

Contact Preferred Pharmaceuticals, Inc. at their Anaheim, CA facility for further instructions regarding this recall.

For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.